Literature DB >> 12222959

RAGE is a multiligand receptor of the immunoglobulin superfamily: implications for homeostasis and chronic disease.

L G Bucciarelli1, T Wendt, L Rong, E Lalla, M A Hofmann, M T Goova, A Taguchi, S F Yan, S D Yan, D M Stern, A M Schmidt.   

Abstract

Receptor for AGE (RAGE) is a member of the immunoglobulin superfamily that engages distinct classes of ligands. The biology of RAGE is driven by the settings in which these ligands accumulate, such as diabetes, inflammation, neurodegenerative disorders and tumors. In this review, we discuss the context of each of these classes of ligands, including advance glycation end-products, amyloid beta peptide and the family of beta sheet fibrils, S100/calgranulins and amphoterin. Implications for the role of these ligands interacting with RAGE in homeostasis and disease will be considered.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12222959     DOI: 10.1007/s00018-002-8491-x

Source DB:  PubMed          Journal:  Cell Mol Life Sci        ISSN: 1420-682X            Impact factor:   9.261


  80 in total

1.  PF-04494700, an oral inhibitor of receptor for advanced glycation end products (RAGE), in Alzheimer disease.

Authors:  Marwan N Sabbagh; Albert Agro; Joanne Bell; Paul S Aisen; Edward Schweizer; Douglas Galasko
Journal:  Alzheimer Dis Assoc Disord       Date:  2011 Jul-Sep       Impact factor: 2.703

Review 2.  The receptor for advanced glycation end products and acute lung injury/acute respiratory distress syndrome.

Authors:  Weidun Alan Guo; Paul R Knight; Krishnan Raghavendran
Journal:  Intensive Care Med       Date:  2012-07-10       Impact factor: 17.440

Review 3.  Uremic Toxicity of Advanced Glycation End Products in CKD.

Authors:  Andréa E M Stinghen; Ziad A Massy; Helen Vlassara; Gary E Striker; Agnès Boullier
Journal:  J Am Soc Nephrol       Date:  2015-08-26       Impact factor: 10.121

4.  The effects of the receptor for advanced glycation end products (RAGE) on bone metabolism under physiological and diabetic conditions.

Authors:  Yasuhiro Hamada; Sohei Kitazawa; Riko Kitazawa; Keiji Kono; Shunsuke Goto; Hirotaka Komaba; Hideki Fujii; Yasuhiko Yamamoto; Hiroshi Yamamoto; Makoto Usami; Masafumi Fukagawa
Journal:  Endocrine       Date:  2010-10-23       Impact factor: 3.633

5.  Statins stimulate the production of a soluble form of the receptor for advanced glycation end products.

Authors:  Patricia Quade-Lyssy; Anna Maria Kanarek; Markus Baiersdörfer; Rolf Postina; Elzbieta Kojro
Journal:  J Lipid Res       Date:  2013-08-21       Impact factor: 5.922

6.  Genetic analysis of advanced glycation end products in the DHS MIND study.

Authors:  Jeremy N Adams; Laura M Raffield; Susan E Martelle; Barry I Freedman; Carl D Langefeld; J Jeffrey Carr; Amanda J Cox; Donald W Bowden
Journal:  Gene       Date:  2016-02-23       Impact factor: 3.688

7.  Theoretical studies on models of lysine-arginine cross-links derived from α-oxoaldehydes: a new mechanism for glucosepane formation.

Authors:  Rasoul Nasiri; Mansour Zahedi; Hélène Jamet; Ali Akbar Moosavi-Movahedi
Journal:  J Mol Model       Date:  2011-08-03       Impact factor: 1.810

8.  Decreased plasma levels of soluble receptor for advanced glycation end products in mild cognitive impairment.

Authors:  R Ghidoni; L Benussi; M Glionna; M Franzoni; D Geroldi; E Emanuele; G Binetti
Journal:  J Neural Transm (Vienna)       Date:  2008-05-28       Impact factor: 3.575

9.  In skeletal muscle advanced glycation end products (AGEs) inhibit insulin action and induce the formation of multimolecular complexes including the receptor for AGEs.

Authors:  Angela Cassese; Iolanda Esposito; Francesca Fiory; Alessia P M Barbagallo; Flora Paturzo; Paola Mirra; Luca Ulianich; Ferdinando Giacco; Claudia Iadicicco; Angela Lombardi; Francesco Oriente; Emmanuel Van Obberghen; Francesco Beguinot; Pietro Formisano; Claudia Miele
Journal:  J Biol Chem       Date:  2008-10-27       Impact factor: 5.157

10.  RAGE-mediated signaling contributes to intraneuronal transport of amyloid-beta and neuronal dysfunction.

Authors:  Kazuhiro Takuma; Fang Fang; Wensheng Zhang; Shiqiang Yan; Emiko Fukuzaki; Heng Du; Alexander Sosunov; Guy McKhann; Yoko Funatsu; Noritaka Nakamichi; Taku Nagai; Hiroyuki Mizoguchi; Daisuke Ibi; Osamu Hori; Satoshi Ogawa; David M Stern; Kiyofumi Yamada; Shirley Shidu Yan
Journal:  Proc Natl Acad Sci U S A       Date:  2009-11-09       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.